We are live on
!
Find out more
Ensign Peak Advisors Portfolio holdings
AUM
$53.7B
1-Year Est. Return
29.47%
This Fund
S&P 500
This Quarter
Est. Return
-3.67%
1 Year Est. Return
+29.47%
3 Year Est. Return
+102.45%
5 Year Est. Return
+139.11%
10 Year Est. Return
–
AUM
$40.3B
AUM Growth
-$1.82B
(-4.3%)
Cap. Flow
+$332M
Cap. Flow
% of AUM
0.83%
Top 10 Holdings %
Top 10 Hldgs %
25.24%
Holding
2,393
New
237
Increased
785
Reduced
642
Closed
83
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Mastercard
MA
|
+$231M |
| 2 |
Gilead Sciences
GILD
|
+$113M |
| 3 |
PG&E
PCG
|
+$102M |
| 4 |
iShares 1-3 Year Treasury Bond ETF
SHY
|
+$80.2M |
| 5 |
Allstate
ALL
|
+$64.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$472M |
| 2 |
AbbVie
ABBV
|
+$121M |
| 3 |
iShares MSCI USA Value Factor ETF
VLUE
|
+$69.5M |
| 4 |
Salesforce
CRM
|
+$64.3M |
| 5 |
Home Depot
HD
|
+$62.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.24% |
| 2 | Healthcare | 19.03% |
| 3 | Financials | 13.02% |
| 4 | Consumer Discretionary | 9.39% |
| 5 | Industrials | 7.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
901
United Bankshares
UBSI
$6.69B
| $1.46M | ﹤0.01% |
40,863
| – | – |
|
902
Assured Guaranty
AGO
$3.79B
| $1.46M | ﹤0.01% |
30,040
| – | – |
|
903
Cirrus Logic
CRUS
$6.71B
| $1.45M | ﹤0.01% |
21,141
+2,925
| +16% | +$230K |
|
904
Coherent
COHR
$44.9B
| $1.45M | ﹤0.01% |
40,632
+4,750
| +13% | +$227K |
|
|
IMGN
905
DELISTED
Immunogen Inc
IMGN
| $1.44M | ﹤0.01% |
301,826
+261,756
| +653% | +$1.38M |
|
906
Sensata Technologies
ST
$6.7B
| $1.44M | ﹤0.01% |
38,580
-8,155
| -17% | -$342K |
|
|
AKUS
907
DELISTED
Akouos Inc
AKUS
| $1.43M | ﹤0.01% |
212,036
+20,523
| +11% | +$76.8K |
|
908
Kura Oncology
KURA
$798M
| $1.43M | ﹤0.01% |
104,752
+29,426
| +39% | +$454K |
|
909
Rayonier
RYN
$6.62B
| $1.43M | ﹤0.01% |
52,578
+5,935
| +13% | +$192K |
|
|
B
910
Barrick Mining
B
$59.8B
| $1.43M | ﹤0.01% |
84,320
-1,600
| -2% | -$25.2K |
|
911
Ionis Pharmaceuticals
IONS
$9.12B
| $1.43M | ﹤0.01% |
32,315
+7,445
| +30% | +$314K |
|
|
NATI
912
DELISTED
National Instruments Corp
NATI
| $1.43M | ﹤0.01% |
37,827
| – | – |
|
913
Silicon Laboratories
SLAB
$7.17B
| $1.42M | ﹤0.01% |
11,494
-1,100
| -9% | -$147K |
|
|
WWE
914
DELISTED
World Wrestling Entertainment
WWE
| $1.41M | ﹤0.01% |
20,127
-2,920
| -13% | -$199K |
|
915
RH
RH
$3.27B
| $1.41M | ﹤0.01% |
5,713
+225
| +4% | +$60.7K |
|
916
Timken Company
TKR
$9.39B
| $1.41M | ﹤0.01% |
23,794
-4,030
| -14% | -$250K |
|
|
UNVR
917
DELISTED
Univar Solutions Inc.
UNVR
| $1.41M | ﹤0.01% |
61,780
| – | – |
|
918
Royal Gold
RGLD
$16.4B
| $1.4M | ﹤0.01% |
14,963
| – | – |
|
919
Tango Therapeutics
TNGX
$4.23B
| $1.4M | ﹤0.01% |
387,953
+88,562
| +30% | +$378K |
|
920
Lantheus
LNTH
$6.49B
| $1.4M | ﹤0.01% |
19,940
-7,040
| -26% | -$533K |
|
921
Harley-Davidson
HOG
$2.6B
| $1.4M | ﹤0.01% |
40,180
-4,500
| -10% | -$169K |
|
922
Sonic Automotive
SAH
$3.5B
| $1.4M | ﹤0.01% |
32,367
-611
| -2% | -$27.7K |
|
923
Zions Bancorporation
ZION
$10.1B
| $1.4M | ﹤0.01% |
27,520
+11,920
| +76% | +$652K |
|
924
AMN Healthcare
AMN
$1.35B
| $1.38M | ﹤0.01% |
13,027
-2,160
| -14% | -$237K |
|
925
Sunrun
RUN
$2.28B
| $1.37M | ﹤0.01% |
49,560
-12,490
| -20% | -$388K |
|
Similar funds
SCP
Ensign Peak Advisors's Q3 2022 Portfolio in Review
As of Q3 2022, Ensign Peak Advisors held 2,393 positions worth $40.3B, down 4.3% from $42.1B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Ensign Peak Advisors's Q3 2022 filing shows 237 new, 785 increased, 642 reduced and 83 closed positions. Its largest new stake was iShares 1-3 Year Treasury Bond ETF: 975,000 shares worth $79.2M. The largest sale was Visa, an estimated $472M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 20% a quarter earlier, followed by Healthcare and Financials.
- Ensign Peak Advisors's largest Q3 2022 buy was iShares 1-3 Year Treasury Bond ETF: 975,000 shares worth $79.2M.
- Ensign Peak Advisors added most to Mastercard in Q3 2022, an estimated $231M increase.
- Ensign Peak Advisors's biggest Q3 2022 reduction was AbbVie, cutting an estimated $121M.
- Ensign Peak Advisors fully exited Visa in Q3 2022, selling an estimated $472M.
- Ensign Peak Advisors's ten largest holdings make up 25% of its $40.3B portfolio in Q3 2022.
- Ensign Peak Advisors opened 237 new positions and closed 83 in Q3 2022.
- Ensign Peak Advisors's portfolio value fell 4.3% quarter-over-quarter to $40.3B.
Based on Ensign Peak Advisors's 13F filing for Q3 2022, filed 14 Nov 2022.